当前位置: X-MOL 学术JAMA Neurol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Challenges and Opportunities for the Promising Biomarker Blood Neurofilament Light Chain.
JAMA Neurology ( IF 20.4 ) Pub Date : 2023-04-03 , DOI: 10.1001/jamaneurol.2023.0394
Ahmed Abdelhak 1 , Jens Kuhle 2, 3 , Ari J Green 1
Affiliation  

This Viewpoint describes the benefits and limitations of using neurofilament light chain (NfL) as a marker of real-time disease activity and treatment response in multiple sclerosis.

中文翻译:

有前途的生物标志物血液神经丝轻链的挑战和机遇。

该观点描述了使用神经丝轻链 (NfL) 作为多发性硬化症实时疾病活动和治疗反应的标志物的好处和局限性。
更新日期:2023-04-03
down
wechat
bug